CXCL1 and asthma: In vitro experiments showed that CXCL1 production in antigen‐stimulated pulmonary myeloid cells is regulated by de novo ceramide production, suggesting that altered sphingolipid metabolism in these innate immune cells might contribute to asthma pathogenesis independent of changes in global lung ceramide levels.